France, May 14 -- Orange Business is leveraging its expertise to support the Curie Institute in optimizing an artificial intelligence (AI) tool used by doctors. This partnership, initiated by an Orange Business employee affected by the disease, aims to improve the diagnosis of cancers of unknown origin and personalize their therapeutic approach.Cancers of unknown primary origin (CUP) account for approximately 2 to 3% of cancers diagnosed each year in France, representing around 7,000 patients. In France, Institut Curie is the national coordinator of the multidisciplinary consultation meeting (reunion de concertation pluridisciplinaire - RCP) dedicated to cancers of unknown primary. Since its establishment in 2020, 442 patients have been enr...